Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cyproterone is a synthetic steroidal antiandrogen and progestin used primarily in the treatment of prostate cancer and to control hypersexuality in men. In women (as cyproterone acetate combined with estrogen), it is used for severe acne and hirsutism. Its mechanism of action involves blocking androgen receptors to prevent testosterone and dihydrotestosterone from binding to their targets in tissues such as the prostate. It also suppresses luteinizing hormone secretion via negative feedback on the hypothalamo-pituitary axis, reducing testicular testosterone production. Additionally, it has progestational effects by activating progesterone receptors[1][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cyproterone.